Mechanism-based screening: Discovery of the next generation of anthelmintics depends upon more basic research

International Journal for Parasitology

Volumn 29, Issue 1, 1999, Pages 105-112

  Geary, Timothy G ^a   Thompson, David P ^a   Klein, Ronald D ^a  

^a PFIZER INC   (United States)

Author keywords

Anthelmintic; Caenorhabditis elegans; Drug discovery; Mechanism based screening; Nematode

Indexed keywords

ANTHELMINTIC AGENT;

CAENORHABDITIS ELEGANS; DRUG DESIGN; DRUG DEVELOPMENT; DRUG SCREENING; NEMATODE; NONHUMAN; REVIEW;

ANIMALIA; CAENORHABDITIS ELEGANS; VERMES;

EID: 0032894150     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(98)00170-2     Document Type: Article

References (40)

1. Klein RD, Geary TG. Recombinant microorganisms as tools for high throughput screening for nonantibiotic compounds. J Biomol Screen 1997;2:41-49.
2. Kuntz ID. Structure-based strategies for drug design and discovery. Science 1992;257:1078-1082.
3. Whittle PJ, Blundell TL. Protein structure-based drug design. Annu Rev Biophys Biomol Struct 1994;23:349-375.
4. Colman PM. Structure-based drug design. Curr Opin Struct Biol 1995;4:868-874.
5. Ring CS, Sun E, McKerrow JH, et al. Structure-based inhibitor design by using protein models for the development of antiparasitic agents. Proc Natl Acad Sci USA 1993;90:3583-3587.
6. Brownstein MJ. A brief history of opiates, opioid peptides and opioid receptors. Proc Natl Acad Sci USA 1993;90:5391-5399.
7. Goldstein A, Lowney LI, Pal BK. Stereospecific and non-specific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proc Natl Acad Sci USA 1971;68:1742-1747.
8. Williams M. Receptor binding in the drug discovery process. Med Res Rev 1991;11:147-184.
9. Sweetnam PM, Caldwell L, Lancaster J, et al. The role of receptor binding in drug discovery. J Nat Prod 1993;56:441-445.
10. Chang RSL, Lotti VJ, Monaghan RL, et al. A potent non-peptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaccus. Science 1985;230:177-179.
11. Evans BE, Rittle KE, Bock MG, et al. Methods for drug discovery: Development of potent, selective, orally effective cholecystokinin antagonists. J Med Chem 1988;31:2235-2246.
12. Broach JR, Thorner J. High-throughput screening for drug discovery. Nature 1996;384(Suppl):14-16.
13. Trias J, Gordon EM. Innovative approaches to novel antibacterial drug discovery. Curr Opin Biotechnol 1997;8:757-762.
14. Harding D, Banks M, Fogarty S, Binnie A. Development of an automated high-throughput screening system: A case history. Drug Discov Today 1997;2:385-390.
15. Hemmila I, Webb S. Time-resolved fluorometry: An overview of the labels and core technologies for drug screening applications. Drug Discov Today 1997;2:373-381.
16. Houston JG, Banks M. The chemical-biological interface-developments in automated and miniaturised screening technology. Curr Opin Biotechnol 1997;8:734-740.
17. Sittampalam GS, Kahl SD, Janzen WP. High-throughput screening-advances in assay technologies. Curr Opin Chem Biol 1997;1:384-391.
18. Gordon EM. Barrett RW, Dower WJ, Fodor SPA,Gallop MA. Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions. J Med Chem 1994;37:1385-1401.
19. Gordon EM, Gallop MA, Patel DV. Strategy and tactics in combinatorial organic synthesis. Application to drug discovery. Acct Chem Res 1996:29:144-154.
20. Hall SE. The future of combinatorial chemistry as a drug discovery paradigm. Pharm Res 1997;14:1104-1105.
21. Huc I, Kehn J-M. Virtual combinatorial libraries: Dynamic generation of molecular and supramolecular diversity by self-assembly. Proc Natl Acad Sci USA 1997;94:2106-2110.
22. Pausch MH. G-protein-coupled receptors in Saccharomyces cererisiae-high-throughput screening assays for drug discovery. Trends Biotechnol 1997:15:487-494.
23. Simpkin KG, Coles GC. The use of Caenorhabditis elegans for anthelmintic screening. J Chem Tech Biotechnol 1981;31:66-69.
24. Conder GA, Johnson SS, Guimond PM, Cox DL, Lee BL. Concurrent infections with the ruminant nematodes Haemonchus contortus and Trichostrongylus colubriformis in jirds, Meriones unguiculatus, and use of this model for anthelmintic studies. J Parasitol 1991;77:621-623.
25. Waterston RH, Sulston JE, Coulson AR. The genome. In: Riddle DL, Blumenthal T, Meyer BJ, Preiss JR, editors. C. Elegans, vol. II. Plainview. NY: Cold Spring Harbor Laboratory Press, 1997;23-45.
26. Kingsbury DT. Bioinformatics in drug discovery. Drug Dev Res 1997;41:120-128.
27. Plasterk RH. Postsequence genetics of Caenorhabditis elegans. Genome Res 1996;6:169-175.
28. Zwaal RR, Broeks A, Van Meurs J, Groenen JTM, Plasterk RHA. Target-selected gene inactivation in Caenorhabditis elegans, using a frozen transposon insertion mutant bank. Proc Natl Acad Sci USA 1993:90:7431-7435.
29. Plasterk RH. Reverse genetics: From gene sequence to mutant worm. Methods Cell Biol 1995;48:59-80.
30. Yandell MD, Edgar LG, Wood WB. Trimethylpsoralen induces small deletion mutations in Caenorhabditis elegans. Proc Natl Acad Sci USA 1994;91:1381-1385.
31. Jansen G, Hazendonk E, Thijssen KL, Plasterk RH. Reverse genetics by chemical mutagenesis in Caenorhabditis elegans. Nat Genet 1997;17:119-121.
32. Fire A, Xu SQ, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806-811.
33. Rand JB, Johnson CD. Genetic pharmacology: Interactions between drugs and gene products in Caenorhabditis elegans. Methods Cell Biol 1995;48:187-204.
34. Janke DL, Schein JE, Ha T. et al. Interpreting a sequenced genome: Toward a cosmid transgenic library of Caenorhabditis elegans. Genome Res 1997;7:974-985.
35. Blaxter ML. The filarial genome network. Parasitol Today 1995;11:441-442.
36. Blaxter ML, Bird D. Parasitic nematodes. In: Riddle DL, Blumenthal T, Meyer BJ, Priess JR, editors. C. Elegans, vol. II. Plainview, NY: Cold Spring Harbor Laboratory Press, 1997;851-78.
37. Kwa MS, Veenstra JG, Van Dijk M, Roos MH. Beta-tubulin genes from the parasitic nematode Haemonchus contortus modulate drug resistance in Caenorhabditis elegans. J Mol Biol 1995;246:500-510.
38. Aguinaldo AM, Turbeville JM, Linford LS, et al. Evidence for a clade of nematodes, arthropods and other moulting animals. Nature 1997;387:489-493.
39. Geary TG, Blair KL, Ho NFH, Sims SM, Thompson DP. Biological functions of nematode surfaces. In: Boothroyd JC, Komuniecki R, editors. Molecular Approaches to Parasitology. New York: Wiley-Liss, 1995;57-76.
40. Thompson DP, Klein RD, Geary TG. Prospects for rational approaches to anthelmintic discovery. Parasitology 1996;113:S217-S238.